Lyra Therapeutics Inc expected to post a loss of 91  cents a share - Earnings Preview

Lyra Therapeutics

06/05/2022 22:49

* Lyra Therapeutics Inc  LYRA.OQ   LYRA.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 9
(estimated). 
    * The Watertown Massachusetts-based  company is expected to
report
revenue of $1.25 million, according to the mean estimate from 2
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Lyra Therapeutics
Inc is
for a loss of 91 cents per share. For the same quarter last
year, the company reported a loss of 60 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lyra
Therapeutics
Inc is $24​, above​ its last closing price of $5.78. ​​​

This summary was machine generated May 6 at 21:49 GMT.  All
figures in US dollars  unless otherwise stated